Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
March 19, 2004
Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide
B Van Den Bossche, E D'haeninck, F De Vos, et al.
International Journal of Cancer
|
April 15, 1989
Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin beta 3 and increased expression of c-myc
P Krief, C Saint-Ruf, M Bracke, et al.
The European Respiratory Journal
|
May 3, 2005
Severity of obstructive airway disease and risk of osteoporotic fracture
F de Vries, T P van Staa, M S G M Bracke, et al.
European Journal of Cell Biology
|
October 26, 2001
8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells
H Rong, T Boterberg, J Maubach, et al.
Communications in Agricultural and Applied Biological Sciences
|
May 5, 2011
Bacterial modulation of the fasting induced adipose factor (FIAF) in an intestinal cell line model: a potential host-microbe crosstalk related to obesity
C Grootaert, T Van De Wiele, I Van Roosbroeck, et al.
Thrombosis and Haemostasis
|
July 15, 1999
Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease
H Lankhof, C Damas, M E Schiphorst, et al.
Experimental Cell Research
|
October 25, 2016
Quantitative evaluation of single cell spread on collagen matrices
E De Vlieghere, G Wagemans, S De Backer, et al.
Thrombosis and Haemostasis
|
June 1, 1996
A3 domain is essential for interaction of von Willebrand factor with collagen type III
H Lankhof, M van Hoeij, M E Schiphorst, et al.
Thrombosis and Haemostasis
|
May 1, 1997
von Willebrand factor without the A2 domain is resistant to proteolysis
H Lankhof, C Damas, M E Schiphorst, et al.
Pediatrics
|
July 18, 2012
Quality improvement initiative to reduce serious safety events and improve patient safety culture
Stephen E Muething, Anthony Goudie, Pamela J Schoettker, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
European Journal of Nuclear Medicine and Molecular Imaging
|
March 19, 2004
Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide
B Van Den Bossche, E D'haeninck, F De Vos, et al.
International Journal of Cancer
|
April 15, 1989
Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin beta 3 and increased expression of c-myc
P Krief, C Saint-Ruf, M Bracke, et al.
The European Respiratory Journal
|
May 3, 2005
Severity of obstructive airway disease and risk of osteoporotic fracture
F de Vries, T P van Staa, M S G M Bracke, et al.
European Journal of Cell Biology
|
October 26, 2001
8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells
H Rong, T Boterberg, J Maubach, et al.
Communications in Agricultural and Applied Biological Sciences
|
May 5, 2011
Bacterial modulation of the fasting induced adipose factor (FIAF) in an intestinal cell line model: a potential host-microbe crosstalk related to obesity
C Grootaert, T Van De Wiele, I Van Roosbroeck, et al.
Thrombosis and Haemostasis
|
July 15, 1999
Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease
H Lankhof, C Damas, M E Schiphorst, et al.
Experimental Cell Research
|
October 25, 2016
Quantitative evaluation of single cell spread on collagen matrices
E De Vlieghere, G Wagemans, S De Backer, et al.
Thrombosis and Haemostasis
|
June 1, 1996
A3 domain is essential for interaction of von Willebrand factor with collagen type III
H Lankhof, M van Hoeij, M E Schiphorst, et al.
Thrombosis and Haemostasis
|
May 1, 1997
von Willebrand factor without the A2 domain is resistant to proteolysis
H Lankhof, C Damas, M E Schiphorst, et al.
Pediatrics
|
July 18, 2012
Quality improvement initiative to reduce serious safety events and improve patient safety culture
Stephen E Muething, Anthony Goudie, Pamela J Schoettker, et al.
Page
of 9